Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).

  • Published 2008 in
    Plastic surgical nursing : official journal of…

Abstract

This information reflects FDA’s current analysis of available data concerning these drugs. Posting this information does not mean that FDA has concluded there is a causal relationship between the drug products and the emerging safety issue. Nor does it mean that FDA is advising healthcare professionals to discontinue prescribing these products. FDA is… (More)
DOI: 10.1097/01.PSN.0000335818.00036.c5

Topics

Cite this paper

@article{2008EarlyCA, title={Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).}, author={}, journal={Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses}, year={2008}, volume={28 3}, pages={150-1} }